Biotech Stock Alert for Health Discovery Corp. Issued by Beacon Equity


DALLAS, Feb. 1, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring Health Discovery Corp. (OTCBB:HDVY). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision. 

The full report is available at: http://www.beaconequity.com/i/HDVY

Get our alerts BEFORE the rest of the market.  Follow us on Twitter: http://twitter.com/BeaconEquity

Health Discovery Corp. (HDVY) is a pattern recognition company that uses mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. The Company operates primarily in the emerging field of molecular diagnostics where such tools are critical to scientific discovery.

Message Board Search for HDVY: http://www.boardcentral.com/boards/HDVY

In the report, the analyst notes:

“As previously announced, HDVY recently entered into royalty-bearing licenses for its new urine-based prostate cancer test with Quest Diagnostics Inc.and Abbott Laboratories for development and commercialization. The Company also entered into royalty-bearing licenses for its tissue biopsy-based prostate cancer test with Abbott Laboratories and Clarient Inc. for development and commercialization.

“The Company’s minority-owned subsidiary, Smart Personalized Medicine LLC, recently entered into a licensing agreement with a world-renowned international cancer center to develop a breast cancer prognostic test. Along with the Company, the subsidiary is currently in discussions with a national clinical laboratory for development and commercialization of the test.”

To read the entire report visit: http://www.beaconequity.com/i/HDVY

See what investors are saying about HDVY at penny stock forum

BeaconEquity.com is one of the industry's largest small-cap report providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com.

Beacon Equity Disclosure

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice. Beacon Equity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.



            

Contact Data

GlobeNewswire